Kura (KURA)
Develops targeted cancer medicines led by KOMZIFTI for genetically defined AML.
$11.71
After hours−0.04 (−0.33%)
At close$11.75(+1.29%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
−$0.84
Revenue estimate
$23.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.22−$0.66−$0.75−$0.85−$0.92−$0.83−$0.77Pending
Estimate−$0.65−$0.51$0.15−$0.57−$0.72−$0.88−$0.88−$0.84
Surprise+66.2%−29.4%−600.0%−49.1%−27.8%+5.7%+12.2%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$53.9M$14.1M$15.3M$20.8M$17.3M$18.3M$20.9MPending
Estimate$58.0M$66.7M$64.9M$51.4M$35.4M$26.0M$20.2M$23.8M
Surprise−7.0%−78.8%−76.5%−59.7%−51.1%−29.7%+3.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.61 | — | — |
| Sep 2027 | −$0.61 | — | — |
| Jun 2027 | −$0.59 | — | — |
| Mar 2027 | −$0.72 | — | — |
| Dec 2026 | −$0.81 | — | — |
| Nov 2026 | −$0.84 | — | — |
| Aug 2026 | −$0.88 | −$0.77 | +12.2% |
| May 2026 | −$0.88 | −$0.83 | +5.7% |
| Mar 2026 | −$0.72 | −$0.92 | −27.8% |
| Nov 2025 | −$0.57 | −$0.85 | −49.1% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.61 | — | — | $57.5M | — | — | — |
| Sep 2027 | −$0.61 | — | — | $52.5M | — | — | — |
| Jun 2027 | −$0.59 | — | — | $47.5M | — | — | — |
| Mar 2027 | −$0.72 | — | — | $41.9M | — | — | — |
| Dec 2026 | −$0.81 | — | — | $33.5M | — | — | — |
| Nov 3, 2026 | −$0.84 | — | — | $23.8M | — | — | — |
| Aug 12, 2026 | −$0.88 | −$0.77 | +12.2% | $20.2M | $20.9M | +3.5% | +1.5% |
| May 12, 2026 | −$0.88 | −$0.83 | +5.7% | $26.0M | $18.3M | −29.7% | −2.1% |
| Mar 5, 2026 | −$0.72 | −$0.92 | −27.8% | $35.4M | $17.3M | −51.1% | −0.5% |
| Nov 4, 2025 | −$0.57 | −$0.85 | −49.1% | $51.4M | $20.8M | −59.7% | +1.9% |
| Aug 7, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 10, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 4, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 1, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 5, 2019 | |||||||
| Nov 5, 2018 | |||||||
| Aug 6, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 12, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 7, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 14, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 10, 2016 | |||||||
| May 11, 2016 | |||||||
| Mar 17, 2016 | |||||||
| Nov 13, 2015 | |||||||
| Aug 14, 2015 |